Jillian P Rhoads Selected Research

Jillian P Rhoads Research Topics

21	COVID-19 05/2023 - 02/2021
3	Critical Illness (Critically Ill) 08/2023 - 01/2023
3	Inflammation (Inflammations) 10/2021 - 01/2018
3	Atherosclerosis 01/2019 - 01/2017
2	Infections 01/2023 - 01/2022
2	Disease Progression 10/2022 - 11/2021
1	Hypoxia (Hypoxemia) 03/2023
1	Respiratory Insufficiency (Respiratory Failure) 03/2022
1	Vesicular Stomatitis 01/2022
1	Myocardial Infarction 01/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2017
1	Rheumatoid Arthritis 01/2017
1	Chronic Disease (Chronic Diseases) 01/2017
1	Myocarditis (Carditis) 03/2015

12	VaccinesIBA 05/2023 - 09/2021
11	COVID-19 VaccinesIBA 05/2023 - 09/2021
10	mRNA VaccinesIBA 01/2023 - 09/2021
8	Messenger RNA (mRNA)IBA 04/2023 - 11/2021
3	BNT162 VaccineIBA 03/2022 - 11/2021
3	oxidized low density lipoproteinIBA 01/2019 - 01/2017
2	N-(2-cyanoethylene)urea (BA 1)IBA 04/2023 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2022
2	2019-nCoV Vaccine mRNA-1273IBA 03/2022 - 01/2022
2	Immunoglobulin G (IgG)IBA 09/2021 - 02/2021
1	dimemorfan (AT 17)IBA 08/2023
1	Oxygen (Dioxygen)IBA 03/2023
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023
1	AntibodiesIBA 11/2022
1	Ad26COVS1IBA 10/2022
1	Neutralizing AntibodiesIBA 01/2022
1	CholesterolIBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	low density lipoprotein inhibitorIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2017
1	InflammasomesIBA 01/2017
1	CytokinesIBA 03/2015

3	Artificial Respiration (Mechanical Ventilation) 04/2023 - 11/2021
2	Laryngoscopes 08/2023 - 01/2023
2	Therapeutics 01/2022 - 10/2021
1	Noninvasive Ventilation 03/2023